Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Congenital contractural arachnodactyly
0.030 Biomarker disease BEFREE Our results provide further insight into the mechanism underlying the anti-tumor effects of shikonin by TRAIL enhanced in CCA and a new therapeutic strategy to CCA treatment. 28662515 2017
Congenital contractural arachnodactyly
0.030 Biomarker disease BEFREE Our finding suggests TRAIL to be a novel anti-cancer therapeutic agent and advantage of its combination with a conventional chemotherapeutic drug for effective treatment of CCA. 26514480 2015
Congenital contractural arachnodactyly
0.030 AlteredExpression disease BEFREE Cholangiocarcinomas (CCA) paradoxically express the death ligand TRAIL and thus, are dependent on effective survival signals to circumvent apoptosis. 25818805 2015